We are live on ! Find out more
CGTX icon

Cognition Therapeutics

75 hedge funds and large institutions have $16.3M invested in Cognition Therapeutics in 2026 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 18 increasing their positions, 14 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 14

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.38% less ownership

Funds ownership: 24.35%23.97% (-0.38%)

7% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 14

4% less funds holding

Funds holding: 7875 (-3)

44% less capital invested

Capital invested by funds: $29M → $16.3M (-$12.8M)

Holders
75
Holders Change
-3
Holders Change %
-3.85%
% of All Funds
0.92%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
13
Increased
18
Reduced
14
Closed
14
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
ML
26
McAdam LLC
Pennsylvania
$53.1K -$4.84K -4,156 -6%
VF
27
Virtu Financial
New York
$53K +$35.1K +30,174 +75%
CFM
28
Catalyst Funds Management
Australia
$40.1K +$61.5K +52,800 New
FC
29
FCA Corp
Texas
$39.9K
CWM
30
Circle Wealth Management
New Jersey
$37.1K
EWM
31
Empirical Wealth Management
Washington
$36.5K
Raymond James Financial
32
Raymond James Financial
Florida
$36.1K -$1.16K -1,000 -2%
Cetera Investment Advisers
33
Cetera Investment Advisers
Illinois
$31.3K
EFS
34
Essex Financial Services
Connecticut
$30.4K +$23.3K +20,000 +100%
Jones Financial Companies
35
Jones Financial Companies
Missouri
$25.9K +$6.68K +5,741 +19%
BSB
36
Bangor Savings Bank
Maine
$25.8K
TSS
37
Two Sigma Securities
New York
$24.2K +$3.75K +3,223 +11%
Creative Planning
38
Creative Planning
Kansas
$22.9K +$233 +200 +0.7%
GF
39
Gabelli Funds
New York
$22.8K +$34.9K +30,000 New
BMCM
40
Bryn Mawr Capital Management
Pennsylvania
$22.1K
Morgan Stanley
41
Morgan Stanley
New York
$21.2K -$76.2K -65,455 -70%
Squarepoint
42
Squarepoint
New York
$20.2K +$18.8K +16,153 +155%
Citadel Advisors
43
Citadel Advisors
Florida
$19.7K -$157K -135,296 -84%
CAMG
44
CWA Asset Management Group
Florida
$19.2K
HighTower Advisors
45
HighTower Advisors
Illinois
$18.2K
PMG
46
Private Management Group
California
$18.2K
VGA
47
Vanguard Global Advisers
Pennsylvania
$18K +$27.5K +23,641 New
GI
48
GAMCO Investors
Connecticut
$15.2K
Rockefeller Capital Management
49
Rockefeller Capital Management
New York
$14.6K
Two Sigma Investments
50
Two Sigma Investments
New York
$14.6K -$33.2K -28,500 -60%

CGTX Hedge Fund Activity: Q1 2026 in Review

75 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Cognition Therapeutics (CGTX) for Q1 2026, worth a combined $16.3M — down 44% from $29M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of CGTX and 13 opened new positions — a net loss of 1 holder — while 14 trimmed existing stakes and 18 added.

The largest buyer was CM Management, adding an estimated $233K. The largest seller was Jane Street, cutting an estimated $284K.

  • 75 institutional investors held Cognition Therapeutics (CGTX) as of Q1 2026, down from 78 in Q4 2025.
  • Funds reported $16.3M of Cognition Therapeutics stock for Q1 2026, down 44% quarter-over-quarter.
  • 13 funds opened new Cognition Therapeutics positions in Q1 2026 and 14 closed out, a net change of -1 holder.
  • The largest Cognition Therapeutics buyer in Q1 2026 was CM Management, an estimated $233K added.
  • The largest Cognition Therapeutics seller in Q1 2026 was Jane Street, an estimated $284K sold.

Based on aggregated 13F filings for Q1 2026.